None listed
Conditions
Interventions
placebo intake
test food intake
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults 20 to 65 years age 2) Subjects whose BMI of 18.5 to 30 kg/m^2 3) Subjects giving written informed consent
Exclusion criteria
Exclusion criteria: 1) Subjects who regularly use medication affecting obesity, hyperlipidemia, lipid metabolism. 2) Subjects who cantract serious diseases (e.g., liver disease, heart disease, respiratory disease, endocrine disease, metabolic disorder, food allergic disease.) 3) Subjects who can't stop using supplements and/or functional foods affecting obesity, hyperlipidemia, lipid metabolism. 4) Subjects whoare under treatment for or have a history of drug addication and/or alcoholism. 5) Subjects who can't stop drinking from 2 days before each inspection date. 6) Subjects who have medical history of deseases or surgeries which affect digestion and absorption. 7) Phenylketonuria, and hyperphenylalaninemia 8) Subjects who have been diagnosed with familial hyperlipidemia 9) Subjects who are pregnant or nursing, or who wish to become pregnant during the study. 10) Subjects whose eating habits are extremely irregulae (ex. midnight and irregulae shift worker) 11) Subjects who are planning to participate in other clinical studies. 12) Subjects who are judged as unsuitable for the study by the investigator for other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematologic test Biochemistry test Urinalysis Blood pressure/pulse Weight/body mass index Medical interview Adverse event | — |
Countries
Japan
Contacts
Public ContactEiji Yoshikawa
KSO Corporation Sales department
Outcome results
None listed